Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

s (b) 3,754 - 3,754 -

Total purchase accounting

adjustments, pre-tax 4,080 - 4,080 -

Income tax benefit 89 - 89 -

Total purchase

accounting

adjustments $ 3,991 $- $ 3,991 $-

Acquisition-related items:

Acquisition-related

(gains)/losses on

currency-related and

interest-related items (c) $ (255) $- $ (537) $-

Integration-related

activities (d) 52 - 84 -

Total acquisition-related

items, pre-tax (203) - (453) -

Income tax benefit 2 - 2 -

Total acquisition-

related items $ (205) $- $ (455) $-

Other specified items:

Manufacturing changes

announced June 1, 2006 (e) $- $57 $- $ 248

Upfront R&D payments (b) 21 15 197 15

Change in accounting

principle (f) - - - (22)

Total other specified

items, pre-tax 21 72 197 241

Income tax benefit 1 - 1 -

Total other

specified items $20 $72 $196 $241

Total purchase

accounting adjustments,

acquisition-related

items and other

specified items $ 3,806 $72 $3,732 $241

(a) Included in cost of sales

(b) Included in research and development

(c) Included in other (income)/expense, net

(d) Included in special and acquisition-related charges

(e) Included in cost of sales an
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... AZ (PRWEB) July 11, 2014 ... device company specializing in the soft tissue reconstruction ... All-Suture Anchor System for surgeries involving the shoulder ... fixation through a novel, inserter-controlled deployment method. The ... to partial deployment, anchor pull-out, or anchor displacement ...
(Date:7/10/2014)... (PRWEB) July 10, 2014 Understanding the ... channel-expressing cell lines, and the gap that currently exists ... that expand its industry-leading portfolio of validated ion channel ... ion channel-expressing cell lines, as ion channels control many ... control this activity creates the potential to treat a ...
(Date:7/10/2014)... CA (PRWEB) July 10, 2014 OMICS ... Bioanalytical techniques during 18-20 August, 2014 at Double Tree ... review the recent developments in Analytical & Bioanalytical research ... globe. , Speaking on this occasion, Dr. Srinubabu Gedela, ... Analytica Acta conference is a remarkable one in bringing ...
(Date:7/10/2014)... 2014 On July 9 Prime ... presented Russia,s first national "Industry" ... Company is developing a unique project called MabNext ... a number of innovative drugs based on monoclonal antibodies ... took place at the International Exhibition "Innoprom 2014" in ...
Breaking Biology Technology:Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2
... YORK, Sept. 24 Stephen Simes, chief executive,officer ... (http://www.biosantepharma.com ) will be featured in an exclusive ... at 10:30 a.m. EDT. The interview,will be posted ... on September 26. The interview will cover ...
... Kendle (Nasdaq: KNDL ), a,leading, global ... President and Chief Financial Officer Karl,"Buzz" Brenkert, III ... at the Grand Hyatt New York, Park Avenue ... Kendle,s presentation is scheduled for,Wednesday, Sept. 26 at ...
... WILMINGTON, Mass., Sept. 24 OmniSonics Medical,Technologies, Inc., ... vascular disease, today announced the appointment of J. ... Board. Mr. Cole is a founding partner ... focuses exclusively on emerging healthcare technology,companies. He brings ...
Cached Biology Technology:WallSt.net Announces Upcoming Interview with CEO of BioSante Pharmaceuticals 2Kendle to Present at the UBS Global Life Sciences Conference 2OmniSonics Appoints J. Daniel Cole Chairman of the Board 2
(Date:7/11/2014)... University, Sweden, have explored two different ways that ... leading to the formation of oxygen molecules in ... the scientific journal Nature Communications . , ... synthetic catalysts for water oxidation, which are key ... direct storage of solar energy in fuels like ...
(Date:7/11/2014)... under the normal circumstances, astrocytes participate in ... environment, and exhibit therapeutic and repairing effects ... studies have found that nerve cells differentiated ... have reduced viability, which produces influences on ... Kailuan General Hospital, Hebei United University, China ...
(Date:7/10/2014)... and other major cities in New Mexico, nearly every ... wastewater rather than precious potable water supplies. Across the ... all golf courses receive treated effluent. Reusing the effluent ... golf courses and homeowners alike fertilize their lawns during ... nitrate. A New Mexico State University turfgrass expert has ...
Breaking Biology News(10 mins):Molecular snapshots of oxygen formation in photosynthesis 2'Tailored' water -- the latest in lawn care 2
... explain the response of patients with chronic obstructive pulmonary ... reported today (Oct. 25) at the American Society of ... used statistical methods to combine results from four individual ... moderate to severe COPD. Over 6.3 million unique ...
... cells. They,re equally indispensible in both cases. Without our bony ... cytoskeletons, our cells, which come in roughly 200 different shapes ... Using cells from the stem of a seedling as ... St. Louis seeks to understand the molecular mechanisms that organize ...
... is hosting the region,s leading scientists for discussions ... most devastating and intractable diseases of humans, including ... fungal meningitis. The Cell Biology of Eukaryotic ... campus and provides an environment for scientific discussions ...
Cached Biology News:DNA variants may influence COPD patients' response to inhaled bronchodilators 2Samurai sword protein makes strategic cuts in cell skeletons 2Samurai sword protein makes strategic cuts in cell skeletons 3Samurai sword protein makes strategic cuts in cell skeletons 4Samurai sword protein makes strategic cuts in cell skeletons 5
...
... Modification Services ,,GenScript offers many ... and antibody fragmentation. Labeling antibodies with ... visualization and quantitation of the target ... preferable to use only the antigen-binding ...
... are designed for ultra-sensitive detection of ... PVDF membranes. Since all necessary reagents ... antibodies), the WesternBreeze Kits save you ... and getting your final results. Solutions ...
Request Info...
Biology Products: